Revance Therapeutics, Inc


Updates from The Motley Fool

Latest updates on Revance Therapeutics from Fool.com.


Stock Performance

View Interactive RVNC Charts
Sponsored by

Key Data Points

Primary metrics and data points about Revance Therapeutics.
Current Price: $18.05
Prev Close: $17.85
Open: $17.95
Bid: $12.15
Ask: $20.40
Day's Range: $16.85 - $18.15
52wk Range: $12.35 - $39.26
Volume: 203,266
Avg Vol 213,384
Market Cap: $507M
P/E (ttm): -5.81
EPS (ttm): ($3.07)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Revance Therapeutics.
CAPS Rating 2 out of 5
 
17 Outperform
3 Underperform
CAPS All Stars
 
4 Outperform
2 Underperform

How do you think Revance Therapeutics will perform against the market?



You pick for Revance Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Revance Therapeutics.

Revance Therapeutics, Inc

  • Exchange: NASDAQ